Biotherapy Services appoints John Chiplin as Chairman We are pleased to announce the key appointment to the BTS Board of Dr John Chiplin PhD as Chairman. John is Managing Director of Newstar Ventures Ltd. and also Chairman of Scancell Holdings plc (LSE:SCLP) and has extensive UK...
8thMarch 2019 Biotherapy Services Limited Exciting Update RAPID-1 Diabetic Foot Ulcer [RAPID-1DFU] Randomised Controlled Trial The Board and Executive Management Team are delighted to announce that the treatment of patients has commenced on the RAPID-1DFU trial. The RAPID Biodynamic Haematogel treatment is the first-in-class, medicinal product under development for the...
Biotherapy Services Limited MHRA approves the RAPID-1DFU clinical trial Company is progressing as planned towards Q1/2019 clinical trials. 8thNovember 2018, Biotherapy Services Ltd. the specialist wound healing service company, today announces that it has secured regulatory approval from the Medicines and Healthcare Regulatory Agency (MHRA) for the commencement...
Biotherapy Services Limited We are pleased to announce the appointment of James Rickard as Chief Scientific and Regulatory Officer James has over 17 years’ experience as a clinical pharmacist leading technical services and clinical trials within the NHS. Most recently James was the Deputy chief pharmacist for Barts...
Biotherapy Services Limited MHRA approves licence MIA/(IMP) for the point-of-care manufacture of RAPIDTM Biodynamic Haematogel treatment. Biotherapy Services Ltd. announces the granting of the MIA/(IMP) and “Specials” licences for our proprietary RAPIDTM Biodynamic Haematogel wound care treatment for complex and chronic wounds, was issued on 8thAugust 2018 For further information,...